Polypeptide nanovehicle co-encapsulating doxorubicin and quercetin for a synergistic combination to enhance chemotherapeutic activity in solid tumors

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-FDP-039
• By: YONG, Chul Soon (Yeungnam University, Gyeongsan-Si, Korea, Republic Of)
• Co-author(s): Woo Hyun Shin: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Hima Bindu Ruttala: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Phung Cao Dai: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Myung-Ja Hong: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Jee-Heon Jeong: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Dong Shik Kim: Hanyang University, Ansan-si, Korea, Republic Of
  Han-Gon Choi: Hanyang University, Ansan-si, Korea, Republic Of
  Chul Soon Yong: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  Jong Oh Kim: Yeungnam University, Gyeongsan-Si, Korea, Republic Of
  
• Abstract:

  Background

  In this study, we report a facile method to construct bioactive and biodegradable polypeptide nanovehicles as an advanced platform technology for application in cancer therapy.

  Purpose

  We have synthesized a bioactive (poly(phenylalanine)-b-poly(L-histidine)-b-poly(ethylene glycol) polypeptide nanoconstruct to co-load doxorubicin (DOX) and..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login